ANAB
ANAB
NASDAQ · Biotechnology

Anaptysbio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$56.61
+1.84 (+3.36%)
As of Aug 8, 10:09 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -8.5% upside
Low Target $39.42
Average Target $51.79
High Target $66.87
Current Price $56.61
Current
$56.61
Target
$51.79
$39.42 $51.79 avg $66.87
Scenario Analysis
Bear Case
$39.42
-30.4%
Low target
Base Case
$51.79
-8.5%
Avg target
Bull Case
$66.87
+18.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$72.36
-21.8% from high
52-Week Low
$11.40
+396.6% from low
Target vs 52W High
$51.79
-28.4% vs high
Next Earnings Report
Aug 10, 2026 · After Market Close
Today
EPS Est: $-0.07
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%